Alexander Hicks

Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study.

C. Escriu, A. Addeo, J. Cave, 2022, International immunopharmacology.